Literature DB >> 1491498

Axon reflex flare evoked by nicotine in human skin.

H Izumi1, K Karita.   

Abstract

(1) The purpose of the present study is to investigate whether or not the vasodilatation evoked by intradermal (I.D.) injection of nicotine is mediated through axon reflex mechanism, and to examine the involvement of histamine receptors or capsaicin-sensitive C-fibers in nicotine-induced vasodilator response, using a band method and a laser Doppler technique. (2) The vasodilator response, whether it was caused by nicotine or histamine, developed as quickly on the uninjected side as on the injected side of the band, while the wheal reaction was elicited only by histamine and was localized in the injection side of the band. (3) Pretreatment with either a local anesthetic (lidocaine) or 1% capasaicin markedly reduced the nicotine- and histamine-induced blood flow responses, whereas pretreatment with antihistaminergic agent (diphenhydramine) showed inhibitory effect to the blood flow response only to histamine. (4) These data suggest that two types of chemical receptors, i.e. the nicotinic and the histamine-sensitive receptors, exist in capsaicin-sensitive C-fibers to elicit axon reflex vasodilatation in human skin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491498     DOI: 10.2170/jjphysiol.42.721

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  2 in total

1.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

2.  Reduced stress and inflammatory responsiveness in experienced meditators compared to a matched healthy control group.

Authors:  Melissa A Rosenkranz; Antoine Lutz; David M Perlman; David R W Bachhuber; Brianna S Schuyler; Donal G MacCoon; Richard J Davidson
Journal:  Psychoneuroendocrinology       Date:  2016-02-20       Impact factor: 4.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.